Largest HMO Wants To Depart Wisconsin's Plan


Wisconsin's largest HMO is dropping out of the state employee health plan, saying that continuing would not be economically feasible.

PrimeCare Health Plan, a unit of United HealthCare Corp., had proposed a 19-percent premium increase for state workers in 1999, but on Sept. 1 told the state that it was dropping out, effective Jan. 1. Meanwhile, other HMOs in the program increased premiums by an average of 9 percent for next year.

The state program covers about 210,000 people, and this year offers 21 HMOs and two indemnity plans. The state pays HMOs a rate equal to 105 percent of the lowest-cost HMO in each county, and employees pay the balance of the premium.

The state's contribution is not adjusted to reflect the health risk of participants, and PrimeCare has calculated that the 2,500 state workers in its plan carry risk that is 30 percent greater than the group as a whole. PrimeCare, which has more than 210,000 enrollees, is also dropping out of the Federal Employees Health Benefits Program in the state, citing reasons similar to those that led it to exit the state plan.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.